Manufacturers of food products containing CBD and other cannabinoid derivatives must submit a Novel Foods application in line with the Novel Foods Regulation in order to sell their products in the European Union.
Category: Other Cannabinoids
A physician’s education about cannabis medicine, and her patient’s treatment options, should not depend on their state of residence. Patient access should be based on sound science and physicians should receive comprehensive and uniform education regardless of the state in which they practice.
My vote for “the next CBD” goes to cannabinol (CBN). This is based on its growing acclaim as a safe sleep aid with few, if any, side effects.
Will “the next CBD” be CBG, Δ8THC, THCV, or some other cannabinoid? There are arguments for and against each one.